Anti-VEGF therapy with Ranibizumab is shown to be effective among DME patients with lower central retinal thickness….
Read More »Preventing Muscle Loss When Dieting
Doubling the daily allowance of protein may protect against muscle loss during dieting and exercise related weight loss….
Read More »Lack of Sleep Leads to Poor Food Choices
Grocery shopping with sleep deprivation leads to choosing foods higher in calories and with less nutritional value….
Read More »Empagliflozin Shows Promising Results
New clinical trials reveal the new SGLT2 inhibitor lowers HbA1c as well as sitagliptin….
Read More »Cystatin C May Be Superior to Creatinine in Determining CKD Risk
Cystatin C alone, or in combination with creatinine may be a better predictor for renal disease compared to creatinine alone….
Read More »Copeptin Tests May Be Used to Rule Out Acute Coronary Syndrome
Negative copeptin and troponin tests may be used to rule out an acute myocardial infarction….
Read More »Treatment Approaches in Severely Obese Children
Bariatric surgery is not the only effective treatment regimen in severely obese children….
Read More »Positive Association between Coffee Consumption and All-Cause Mortality
Excessive coffee consumption associated with an increased risk of death….
Read More »SGLT2 Inhibitor Misconceptions
SGLT2 Inhibitors are a new class of drugs aimed at type 2 diabetes. This class of medications is based on blocking the re-uptake of glucose by the kidneys. SGLTs function to ensure that glucose entering the kidneys is returned to the bloodstream instead of being passed in the urine. SGLT-2 …
Read More »Affordable Care Act, Part 1 of 3
This we begin a terrific series of Homerun Slides for you on the Afforable Care Act. This first set will cover the Primary Drivers of Healthcare Reform, and then give a brief overview of the goals of the ACA….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.